BMS Selects Medidata Clinical Cloud

Article

Bristol-Myers Squibb will integrate a full suite of Medidata solutions, including Medidata Rave for electronic data capture, management and reporting and Medidata’s RBM solutions, Medidata TSDV and Medidata CSA, into all stages of its drug development process. Medidata has selected Accenture to be its partner for specific elements of the transformation project, which is being accomplished in a phased rollout.

Read the full release here

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.